| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.34e-05 | 146 | 47 | 5 | GO:0016810 | |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 3.24e-05 | 4 | 47 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.50e-04 | 8 | 47 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.93e-04 | 9 | 47 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.41e-04 | 10 | 47 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 2.41e-04 | 10 | 47 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 3.53e-04 | 12 | 47 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 4.16e-04 | 13 | 47 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | G protein-coupled neurotransmitter receptor activity | 4.16e-04 | 13 | 47 | 2 | GO:0099528 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 5.58e-04 | 15 | 47 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 6.37e-04 | 16 | 47 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.00e-03 | 20 | 47 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.11e-03 | 29 | 47 | 2 | GO:0035325 | |
| GeneOntologyMolecularFunction | deaminase activity | 2.90e-03 | 34 | 47 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.90e-03 | 34 | 47 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3.25e-03 | 36 | 47 | 2 | GO:0016814 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 4.19e-03 | 41 | 47 | 2 | GO:0016799 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 4.40e-03 | 42 | 47 | 2 | GO:0042887 | |
| GeneOntologyBiologicalProcess | antibiotic metabolic process | 4.65e-06 | 2 | 45 | 2 | GO:0016999 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipopeptide | 1.39e-05 | 3 | 45 | 2 | GO:0070340 | |
| GeneOntologyBiologicalProcess | lactam metabolic process | 2.78e-05 | 4 | 45 | 2 | GO:0072338 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipoprotein | 2.78e-05 | 4 | 45 | 2 | GO:0042494 | |
| GeneOntologyBiologicalProcess | canalicular bile acid transport | 6.94e-05 | 6 | 45 | 2 | GO:0015722 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 6.94e-05 | 6 | 45 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 6.94e-05 | 6 | 45 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 9.71e-05 | 7 | 45 | 2 | GO:0071716 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.40e-04 | 230 | 45 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.47e-04 | 47 | 45 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | cellular response to bacterial lipoprotein | 2.07e-04 | 10 | 45 | 2 | GO:0071220 | |
| GeneOntologyBiologicalProcess | cellular response to bacterial lipopeptide | 2.07e-04 | 10 | 45 | 2 | GO:0071221 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 2.07e-04 | 10 | 45 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | response to bacterial lipopeptide | 2.07e-04 | 10 | 45 | 2 | GO:0070339 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 2.48e-04 | 56 | 45 | 3 | GO:0045071 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.51e-04 | 410 | 45 | 6 | GO:0046942 | |
| GeneOntologyBiologicalProcess | response to bacterial lipoprotein | 2.53e-04 | 11 | 45 | 2 | GO:0032493 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.58e-04 | 412 | 45 | 6 | GO:0015849 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 3.03e-04 | 12 | 45 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | regulation of toll-like receptor 2 signaling pathway | 3.58e-04 | 13 | 45 | 2 | GO:0034135 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 4.17e-04 | 14 | 45 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 4.17e-04 | 14 | 45 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 4.17e-04 | 14 | 45 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 4.17e-04 | 14 | 45 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | detection of molecule of bacterial origin | 5.48e-04 | 16 | 45 | 2 | GO:0032490 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 5.48e-04 | 16 | 45 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 5.48e-04 | 16 | 45 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 5.48e-04 | 16 | 45 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | activation of NF-kappaB-inducing kinase activity | 6.20e-04 | 17 | 45 | 2 | GO:0007250 | |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 6.83e-04 | 79 | 45 | 3 | GO:0062208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 6.96e-04 | 18 | 45 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 7.77e-04 | 19 | 45 | 2 | GO:0006855 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 7.77e-04 | 19 | 45 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 7.77e-04 | 19 | 45 | 2 | GO:0016553 | |
| GeneOntologyBiologicalProcess | toll-like receptor 2 signaling pathway | 7.77e-04 | 19 | 45 | 2 | GO:0034134 | |
| GeneOntologyBiologicalProcess | organic anion transport | 8.39e-04 | 515 | 45 | 6 | GO:0015711 | |
| GeneOntologyBiologicalProcess | detection of bacterium | 8.62e-04 | 20 | 45 | 2 | GO:0016045 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 8.62e-04 | 20 | 45 | 2 | GO:0039692 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 9.05e-04 | 87 | 45 | 3 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 9.35e-04 | 88 | 45 | 3 | GO:0010232 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 1.03e-03 | 91 | 45 | 3 | GO:0140115 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 1.03e-03 | 91 | 45 | 3 | GO:0045069 | |
| GeneOntologyBiologicalProcess | detection of other organism | 1.14e-03 | 23 | 45 | 2 | GO:0098543 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 1.46e-03 | 26 | 45 | 2 | GO:0042454 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 1.47e-03 | 103 | 45 | 3 | GO:0048525 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 1.58e-03 | 27 | 45 | 2 | GO:0006213 | |
| GeneOntologyBiologicalProcess | DNA modification | 2.08e-03 | 31 | 45 | 2 | GO:0006304 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 2.16e-03 | 421 | 45 | 5 | GO:0044282 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 2.21e-03 | 32 | 45 | 2 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 2.21e-03 | 32 | 45 | 2 | GO:0009164 | |
| GeneOntologyBiologicalProcess | dicarboxylic acid transport | 2.28e-03 | 120 | 45 | 3 | GO:0006835 | |
| GeneOntologyBiologicalProcess | detection of external biotic stimulus | 2.35e-03 | 33 | 45 | 2 | GO:0098581 | |
| GeneOntologyCellularComponent | intracellular canaliculus | 5.14e-05 | 5 | 48 | 2 | GO:0046691 | |
| MousePheno | abnormal glomerular filtration barrier function | 4.30e-05 | 4 | 38 | 2 | MP:0011856 | |
| Domain | Toll-like_receptor | 5.91e-05 | 5 | 46 | 2 | IPR017241 | |
| Domain | APOBEC_N | 3.86e-04 | 12 | 46 | 2 | PF08210 | |
| Domain | APOBEC_N | 3.86e-04 | 12 | 46 | 2 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 5.30e-04 | 14 | 46 | 2 | IPR016192 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 7.88e-04 | 17 | 46 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 7.88e-04 | 17 | 46 | 2 | IPR002125 | |
| Domain | Cytidine_deaminase-like | 7.88e-04 | 17 | 46 | 2 | IPR016193 | |
| Domain | TIR | 1.21e-03 | 21 | 46 | 2 | SM00255 | |
| Domain | TIR | 1.33e-03 | 22 | 46 | 2 | PF01582 | |
| Domain | Cys-rich_flank_reg_C | 1.41e-03 | 90 | 46 | 3 | IPR000483 | |
| Domain | LRRCT | 1.41e-03 | 90 | 46 | 3 | SM00082 | |
| Domain | - | 1.45e-03 | 23 | 46 | 2 | 3.40.50.10140 | |
| Domain | TIR | 1.58e-03 | 24 | 46 | 2 | PS50104 | |
| Domain | ABC_membrane | 1.58e-03 | 24 | 46 | 2 | PF00664 | |
| Domain | TIR_dom | 1.72e-03 | 25 | 46 | 2 | IPR000157 | |
| Domain | ABC_TM1F | 2.15e-03 | 28 | 46 | 2 | PS50929 | |
| Domain | ABC1_TM_dom | 2.15e-03 | 28 | 46 | 2 | IPR011527 | |
| Domain | ArfGap | 2.31e-03 | 29 | 46 | 2 | SM00105 | |
| Domain | ARFGAP | 2.31e-03 | 29 | 46 | 2 | PS50115 | |
| Domain | ArfGAP | 2.31e-03 | 29 | 46 | 2 | IPR001164 | |
| Domain | ArfGap | 2.31e-03 | 29 | 46 | 2 | PF01412 | |
| Domain | LRRCT | 2.81e-03 | 32 | 46 | 2 | PF01463 | |
| Domain | ABC_transporter_CS | 4.80e-03 | 42 | 46 | 2 | IPR017871 | |
| Domain | Rossmann-like_a/b/a_fold | 5.03e-03 | 43 | 46 | 2 | IPR014729 | |
| Domain | - | 5.03e-03 | 43 | 46 | 2 | 3.40.50.620 | |
| Domain | ABC_TRANSPORTER_2 | 6.23e-03 | 48 | 46 | 2 | PS50893 | |
| Domain | ABC_tran | 6.23e-03 | 48 | 46 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.48e-03 | 49 | 46 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 6.74e-03 | 50 | 46 | 2 | IPR003439 | |
| Domain | LRR_8 | 8.58e-03 | 171 | 46 | 3 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 9.42e-03 | 177 | 46 | 3 | IPR003591 | |
| Domain | LRR_TYP | 9.42e-03 | 177 | 46 | 3 | SM00369 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22315281 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25220810 | ||
| Pubmed | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. | 1.94e-06 | 2 | 49 | 2 | 18036178 | |
| Pubmed | Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. | 1.94e-06 | 2 | 49 | 2 | 17083032 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24445834 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 28474755 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26470427 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21852947 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24984237 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25281535 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23222202 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25801567 | ||
| Pubmed | A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. | 1.94e-06 | 2 | 49 | 2 | 22778390 | |
| Pubmed | Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality. | 1.94e-06 | 2 | 49 | 2 | 26296315 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11123271 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25261617 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 29175392 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 5.83e-06 | 3 | 49 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 5.83e-06 | 3 | 49 | 2 | 27602762 | |
| Pubmed | Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. | 5.83e-06 | 3 | 49 | 2 | 19931471 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 286744 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22691411 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25952649 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 5.83e-06 | 3 | 49 | 2 | 22666481 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23626692 | ||
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 5.83e-06 | 3 | 49 | 2 | 24577894 | |
| Pubmed | Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. | 5.83e-06 | 3 | 49 | 2 | 15812078 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24725948 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 5.83e-06 | 3 | 49 | 2 | 16648136 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16081826 | ||
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 5.83e-06 | 3 | 49 | 2 | 23533681 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20702647 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 1541833 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 27356895 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19480556 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23315078 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20980520 | ||
| Pubmed | Epistatic effect of TLR-1, -6 and -10 polymorphisms on organic dust-mediated cytokine response. | 5.83e-06 | 3 | 49 | 2 | 28123183 | |
| Pubmed | Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. | 5.83e-06 | 3 | 49 | 2 | 18752252 | |
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 5.83e-06 | 3 | 49 | 2 | 25589647 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 284359 | ||
| Pubmed | Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists. | 5.83e-06 | 3 | 49 | 2 | 22822027 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20617165 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 5.83e-06 | 3 | 49 | 2 | 39208378 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31943071 | ||
| Pubmed | Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease. | 5.83e-06 | 3 | 49 | 2 | 25028161 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15731092 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25246533 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24511099 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 11095740 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23671100 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17485564 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 5.83e-06 | 3 | 49 | 2 | 31518043 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 5.83e-06 | 3 | 49 | 2 | 20566830 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17273943 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18091991 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16461792 | ||
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 5.83e-06 | 3 | 49 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 5.83e-06 | 3 | 49 | 2 | 25505062 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31595054 | ||
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 5.83e-06 | 3 | 49 | 2 | 24840555 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 5.83e-06 | 3 | 49 | 2 | 17967065 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25605403 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 14966134 | ||
| Pubmed | Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. | 5.83e-06 | 3 | 49 | 2 | 17932345 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20335265 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24112285 | ||
| Pubmed | IFNs activate toll-like receptor gene expression in viral infections. | 5.83e-06 | 3 | 49 | 2 | 11607792 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23151486 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 5.83e-06 | 3 | 49 | 2 | 29593034 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25850295 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31830125 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 9765497 | ||
| Pubmed | Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. | 5.83e-06 | 3 | 49 | 2 | 12077222 | |
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 5.83e-06 | 3 | 49 | 2 | 21998583 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18451040 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24453360 | ||
| Pubmed | TLR1- and TLR6-independent recognition of bacterial lipopeptides. | 5.83e-06 | 3 | 49 | 2 | 16455646 | |
| Pubmed | Toll-like receptor polymorphisms are associated with increased neurosyphilis risk. | 5.83e-06 | 3 | 49 | 2 | 24922103 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 5.83e-06 | 3 | 49 | 2 | 38115583 | |
| Pubmed | Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells. | 5.83e-06 | 3 | 49 | 2 | 24683188 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16177110 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17595379 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23449789 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22150367 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 18056480 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16374251 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 5.83e-06 | 3 | 49 | 2 | 35458563 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22275865 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 5.83e-06 | 3 | 49 | 2 | 18434399 | |
| Pubmed | TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. | 5.83e-06 | 3 | 49 | 2 | 21998742 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17578901 | ||
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 5.83e-06 | 3 | 49 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 5.83e-06 | 3 | 49 | 2 | 18772436 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 22280448 | ||
| Pubmed | Toll-like receptor 1, 2 and 6 polymorphisms: no association with 11 serum cytokine concentrations. | 5.83e-06 | 3 | 49 | 2 | 30028533 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 293683 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 19150103 | ||
| Cytoband | 3q27.1 | 3.85e-04 | 27 | 49 | 2 | 3q27.1 | |
| Cytoband | 4p14 | 9.35e-04 | 42 | 49 | 2 | 4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 2.36e-03 | 67 | 49 | 2 | chr4p14 | |
| GeneFamily | CD molecules|Toll like receptors | 1.44e-04 | 10 | 33 | 2 | 948 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 2.11e-04 | 12 | 33 | 2 | 406 | |
| GeneFamily | ATP binding cassette subfamily C | 2.49e-04 | 13 | 33 | 2 | 807 | |
| GeneFamily | ArfGAPs | 1.65e-03 | 33 | 33 | 2 | 395 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.46e-02 | 394 | 33 | 3 | 471 | |
| GeneFamily | Solute carriers | 3.48e-02 | 395 | 33 | 3 | 752 | |
| Coexpression | WANG_MLL_TARGETS | 1.52e-05 | 306 | 46 | 6 | MM1076 | |
| Coexpression | GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN | 2.62e-05 | 200 | 46 | 5 | M9335 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN | 2.62e-05 | 200 | 46 | 5 | M7161 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.61e-06 | 184 | 48 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.13e-06 | 122 | 48 | 4 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.13e-06 | 122 | 48 | 4 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 171 | 48 | 4 | b0d616699e2110ffd6cf1868ed1f1a29f824e1fc | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 171 | 48 | 4 | e7dbee63cc39230aa12e7868ec78a129160c0d22 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 179 | 48 | 4 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.20e-05 | 180 | 48 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 182 | 48 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 182 | 48 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 182 | 48 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 188 | 48 | 4 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 191 | 48 | 4 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 48 | 4 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 191 | 48 | 4 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | medial-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.08e-05 | 198 | 48 | 4 | 432a26ace5b486695c9a933c0d44b73305b01ded | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.08e-05 | 198 | 48 | 4 | dbd7869483c5a67944cb94ced0ee2c7b999adc2e | |
| ToppCell | medial-Hematologic-Intermediate_Monocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.08e-05 | 198 | 48 | 4 | 8f64bb5cd8c3e2d5ef651821b0d59f67d1ca1a12 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-05 | 200 | 48 | 4 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-05 | 200 | 48 | 4 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| Drug | estradiol-17 beta-glucuronide | 1.16e-05 | 22 | 46 | 3 | ctd:C025483 | |
| Drug | S-(2,4-dinitrophenyl)glutathione | 1.20e-05 | 3 | 46 | 2 | ctd:C030190 | |
| Disease | aspergillosis (is_implicated_in) | 6.62e-05 | 8 | 46 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.83e-04 | 13 | 46 | 2 | EFO_0800474 | |
| Disease | Drug toxicity | 3.09e-04 | 84 | 46 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 3.09e-04 | 84 | 46 | 3 | C0041755 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.19e-04 | 17 | 46 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | tuberculosis (is_implicated_in) | 8.76e-04 | 28 | 46 | 2 | DOID:399 (is_implicated_in) | |
| Disease | Ataxia, Spinocerebellar | 1.29e-03 | 34 | 46 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.29e-03 | 34 | 46 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.29e-03 | 34 | 46 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.29e-03 | 34 | 46 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.29e-03 | 34 | 46 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.29e-03 | 34 | 46 | 2 | C0752124 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.37e-03 | 35 | 46 | 2 | C0752122 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRFQITWFVSWNPCL | 96 | Q96AK3 | |
| QIYRVTWFISWSPCF | 271 | Q9UH17 | |
| RQFLFHWTVNWRFLP | 266 | Q92685 | |
| CSQSWAQWKLWRQRP | 106 | P0DPF5 | |
| CFQSPRLQWVWRTAF | 6 | Q6JQN1 | |
| WRVSWYERFVQPCLV | 26 | O94778 | |
| CVQAFRARNWWVASV | 26 | P09417 | |
| FAGQVVRLTWWAVCR | 191 | Q8NFF2 | |
| ACANIRRVPFAFKWW | 676 | Q6TGC4 | |
| TSWGSWVRCPFEQRR | 276 | Q6ZVW7 | |
| STVNATIWEFCQRPW | 371 | Q5MY95 | |
| RGAFVQQLWDFCVRW | 726 | Q9NRD8 | |
| ACWSDTLQRWFFLPR | 286 | Q8WVQ1 | |
| NLRPWWQNESLAAFR | 666 | P0DPD6 | |
| VVTSFAPQRRAAWWQ | 111 | P55268 | |
| CVFSWITSNRWLAIR | 1196 | Q92887 | |
| RHCTQAWAIRINPWV | 411 | A6NHN6 | |
| ANLCSRVFFWWLNPL | 16 | O15439 | |
| RSWCLRTVCNPWFER | 71 | O43497 | |
| WMCTRVWPSLQDRFS | 71 | Q99871 | |
| RNWAERWFQLQPSCL | 231 | Q9H4E7 | |
| NPWLCNCEILYFRRW | 221 | P07359 | |
| PWFPEFWQHRFQCRL | 366 | Q13255 | |
| WLWPLVAVCTADFFR | 6 | P16444 | |
| AIRNCPWTVALWSRY | 371 | Q15020 | |
| WLLSQACFNFPFWQR | 381 | Q9P2P1 | |
| RIAFWLQWFNSFVNP | 341 | Q9H3N8 | |
| RRIWNNVTRWFVTCV | 181 | P26640 | |
| LGFIIWKPWRQQCTR | 116 | Q8WV83 | |
| RSLVPLFCWLRATFW | 26 | Q8WXG1 | |
| FQPNIFWKVCWAFVT | 671 | Q9Y345 | |
| TWLRSPVQNFCYIFW | 1941 | A0AVI2 | |
| CLSRFLGWWFRQPVL | 11 | Q9BRJ2 | |
| QSWQILARPWRAFFK | 736 | Q96CC6 | |
| PSSVRFTWEQAFLRW | 486 | Q9NZC9 | |
| VIWRFRPNTRELWCY | 1136 | O75592 | |
| FLLNCFVRSPSWQHW | 16 | Q8NH54 | |
| LPWYLRMVCQWTQTR | 606 | Q15399 | |
| SFCPLSLWRWQLYAA | 306 | O96005 | |
| QQLIFPAEARWCFSW | 96 | Q8N4M7 | |
| QWNKRWFVLVDRCLF | 76 | Q9Y2H5 | |
| PRWASWNIGVFICIR | 36 | Q8WU79 | |
| FALCTWALRRSQPGW | 16 | Q8TBR7 | |
| PRWASWNIGVFICIR | 41 | Q8IYB5 | |
| TTWKCLVRVFQFLWP | 261 | Q9Y2C9 | |
| LPWYLRMVCQWTQTR | 611 | Q9Y2C9 | |
| RDCWATFIQPWGSRA | 201 | P37288 | |
| LLVCQWSQWKYRPTR | 526 | C9J2P7 | |
| WWSQQPRRSALCFVV | 26 | Q96AQ2 | |
| IWACLPLRWQQAQAR | 726 | Q6BDS2 | |
| WRFQLWFLGLTCPER | 16 | Q2WGJ8 | |
| PACWLWDFLRRSQQA | 336 | Q6IA69 |